Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Studies have found that patients at high cardiovascular risk often fail to receive evidePalabras claves:Autores:Almeida A.S., Amodeo C., Baldissera V., Baréa J.A.B., Barros E Silva P.G.D.M., Barroso S.L., Becke G.C.M., Bergo R.R., Berwanger O., Brandão Da Silva N., Campos V.B., Caron V., Conte D., Corrêa J.V.S., da Silva N.B., da Silva S.S., da Silva Serra K.C.C., da Silveira L., da Veiga V.d.F.N., Damiani L.P., Dantas J.M.M., de Assis R.M., de Barros E.F., de Figueiredo Neto J.A., de Moraes J.B.d.M.X., de Oliveira Silveira M.G., del Monaco M.I., do Brasil C.K.O.I., do Canto Filho M.J., do Carmo J.B., Domingues L.H., dos Santos E.V., dos Santos J.C., Duro L.N., Esper R.B., Esteves M.W., Feier A.P., Fernandes L.A.B., Filho J.A.S.B., Fonseca F.H., Fortes J.A.R., Gomes S.P.D.C., Gonçalves M.R., Gonzales B.P., Grezzana G.B., Guerra S.D., Guimarães H.P., Izar M.C., Jardim P.C.B.V., Kodama A., Kopittke L., Leães P.E., Lopes C.D., Lopes R.D., Lourenço S., Luiz R.O., Machline-Carrion M.J., Marcela G.d.O.A., Martin J.F.V., Martins G.L., Moraes M.J.D., Nakagawa R.H., Neto E.L., Neves M.F., Nobre F., Octavio Marques Pontes-Neto, Ormundo C., Orto F.T.C.D., Osugue R.K., Pauli C., Piegas L.S., Pinheiro S., Precoma D.B., Ramacciotti E., Ribeiro G.R., Rocha M.d.F., Sampaio B., Santo J.C.M.D.A., Santos J.Y., Santos P.D., SARAIVA J.O.S.E., Sehnem E., Silva A.L., Silva L.d.O., Silva L.P.W., Silva T.P., Silveira F.S., Sirena S.A., Soares R.M., Sousa A.L.L., Souza S.d.A.R., Stein A.T., Tobias J.S.P., Trama L.M., Vicente C.C., Wanderley F.F., Werle L., Woehl J., Ziebell J.V.Fuentes:scopusPantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
ArticleAbstract: Background & Aims: Antiplatelets and anticoagulants are associated with increased upper gastrointestPalabras claves:drug, Heart Disease Prevention, Stomach, ThrombosisAutores:Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Commerford P.J., Connolly S.J., Cook-Bruns N., Dagenais G.R., Dans A.M., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Hori M., Kakkar A.K., Keltai M., Kim J.H., Lanas F.T., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Maggioni A.P., Metsarinne K.P., Moayyedi P., Muehlhofer E., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Shestakovska O., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Verhamme P.B., Vinereanu D., Widimsky P., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusSafety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
ArticleAbstract: Background & Aims: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. TPalabras claves:bacteria, CVD, Reflux, ThrombosisAutores:Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Hori M., Kakkar A.K., Keltai M., Kim J.H., Lanas F.T., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Maggioni A.P., Metsarinne K.P., Moayyedi P., Muehlhofer E., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Shestakovska O., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Verhamme P.B., Vinereanu D., Widimsky P., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusRationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of high cardiovascular risPalabras claves:Autores:Amodeo C., Berwanger O., Brandão Da Silva N., Campos V.B., Damiani L.P., de Melo Barros P.G., Fonseca F.H., Guimarães H.P., Izar M.C., Lopes R.D., Machline-Carrion M.J., Octavio Marques Pontes-Neto, Piegas L.S., Sampaio B., Soares R.M., Stein A.T., Yamashita J.Fuentes:scopusRationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial
ArticleAbstract: Background: Covert vascular disease of the brain manifests as infarcts, white matter hyperintensitiePalabras claves:Anticoagulant, Clinical trial, COGNITION, magnetic resonance imaging, prevention, silent infarctAutores:Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Cook-Bruns N., Dagenais G.R., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Ha J.W., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Wong G., Yuan F., Yusuf S., Zhu J.Fuentes:googlescopus